| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ENANTA PHARMACEUTICALS INC COM | 1,696,147 | 86,249,000 | 11.11% | ||
| 2 | UNITED THERAPEUTICS | 660,186 | 85,487,000 | 11.01% | ||
| 3 | CARDIOVASCULAR SYS INC DEL COM | 2,135,200 | 64,227,000 | 8.27% | ||
| 4 | ANI PHARMACEUTICALS INC COM | 1,090,067 | 61,469,000 | 7.92% | ||
| 5 | AKORN INC | 1,683,485 | 60,942,000 | 7.85% | ||
| 6 | INSYS THERAPEUTICS INC NEW COM NEW | 1,254,247 | 52,879,000 | 6.81% | ||
| 7 | Anacor Pharmaceuticals Inc | 1,469,690 | 47,398,000 | 6.11% | ||
| 8 | ABBVIE INC | 687,900 | 45,016,000 | 5.80% | ||
| 9 | ORTHOFIX INTERNATIONAL NV | 1,436,495 | 43,181,000 | 5.56% | ||
| 10 | PERNIX THERAPEUTICS HLDGS IN | 3,427,789 | 32,187,000 | 4.15% | ||
| 11 | RETROPHIN INC COM | 2,551,535 | 31,231,000 | 4.02% | ||
| 12 | HYPERION THERAPEUTICS INC | 1,251,353 | 30,032,000 | 3.87% | ||
| 13 | OSIRIS THERAPEUTICS INC NEW COM | 1,674,561 | 26,776,000 | 3.45% | ||
| 14 | HEALTHWAYS INC | 1,316,493 | 26,172,000 | 3.37% | ||
| 15 | DERMA SCIENCES INC COM PAR .01 | 1,632,627 | 15,200,000 | 1.96% | ||
| 16 | ADMA BIOLOGICS, INC. | 877,407 | 9,801,000 | 1.26% | ||
| 17 | HEALTHSTREAM INC COM | 321,026 | 9,464,000 | 1.22% | ||
| 18 | PROTALIX BIOTHERAPEUTICS INC | 5,077,338 | 9,342,000 | 1.20% | ||
| 19 | EVERYDAY HEALTH INC | 633,150 | 9,339,000 | 1.20% | ||
| 20 | BIOSCRIP INC | 1,177,145 | 8,228,000 | 1.06% | ||
| 21 | VERICEL CORP | 2,352,940 | 7,153,000 | 0.92% | ||
| 22 | HMS HOLDINGS CORPORATION | 299,246 | 6,326,000 | 0.81% | ||
| 23 | BIOTIME INC | 1,602,550 | 5,978,000 | 0.77% | ||
| 24 | MERUS LABS INTL INC NEW | 1,360,214 | 2,249,000 | 0.29% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-15-000700, filed 2015.02.17).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
